Stock listing

TSXV:LSL LSL Pharma Group Inc Stock

Home listing (TSXV) of LSL Pharma Group Inc

Follow LSL Pharma Group Inc into a list and get an email when it puts out news.

Share price · TSXV:LSL

$0.295 CAD -0.005 (-1.7%)

Close on Oct 14, 2026

LSL Pharma Group Inc logo
Ticker
TSXV:LSL
Asset type
Stock
Exchange
TSXV
Currency
CAD

What changed lately

Latest news

LSL Pharma Group announces CFO transition

Sep 10, 2026

LSL Pharma Group reports record revenues and second quarter 2026 results

Aug 25, 2026

LSL Pharma Group provides update on Steri-Med Pharma manufacturing operations and grants compensation stock options

Jul 6, 2026

LSL Pharma Group secures new Steri-Med commercial agreements expected to generate over $4 million in recurring annual revenues and appoints Alain R. Dugal as new evp & COO

May 28, 2026

LSL Pharma Group reports record revenues and first quarter 2026 results

May 25, 2026

LSL Pharma Group reports its fourth quarter and year-end 2025 results

Apr 30, 2026

LSL Pharma Group Inc. announces its participation in the "2026 bloom burton & co. healthcare investor conference"

Apr 15, 2026

Juno OTC, a wholly-owned subsidiary of LSL Pharma Group, signs binding term sheet with Instapill Private Limited to supply private label Loratadine 10 mg RDT in Canada

Apr 9, 2026

LSL Pharma Group grants stock options

Feb 3, 2026

LSL Pharma Group successfully obtained U.S. FDA certification for the manufacturing of ophthalmic ointments for commercialization in the United States

Jan 28, 2026

All LSL Pharma Group Inc news

LSL Pharma Group Inc on 6ix

News releases
17 in the last 12 months · 37 in all · newest Sep 10, 2026 · oldest 2024

Where LSL Pharma Group Inc is listed

ListingExchangeCountryCurrency
TSXV:LSL · Home listing · This pageTSXVCanadaCAD
Cboe Canada:LSLCboe CanadaCanadaCAD

Log in to ask 6ix AI your own questions about LSL Pharma Group Inc.